Axcella Health Inc.

AXLANASDAQHealthcare

$4.58

+$0.00(+0.00%)

Market Cap$12503400

P/E Ratio—

52W High$4.58

52W Low$4.58

Avg Volume37K

Open$0.36

Beta0.57

Insider Trades Ownership Employees

Axcella Health Inc. (AXLA) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · AXLA · as of Jun 9, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

2.00

Buy/Sell (by trades)

Overall sentiment

BULLISH

↑ Buy 67%Active transactions only · RSU vesting excluded33% Sell ↓

Axcella Health Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

AXLA insider buying and selling by quarter

AXLA insider selling · AXLA insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

14.2M7.1M0

2021 Q1

2021 Q2

2021 Q3

2021 Q4

2022 Q1

2022 Q2

2022 Q4

2023 Q1

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Recent insider transactions

AXLA executive sell shares · AXLA board member insider trading · AXLA insider trading SEC filing

Showing 41 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
Mar 1, 2023	Koziel Margaret Chief Medical Officer	Sale	679	$0.58	$394	24,883	Form 4
Feb 10, 2023	Fehlner Paul SVP & Chief Legal Officer	Sale	5,221	$0.66	$3K	58,081	Form 4
Oct 17, 2022	Hinshaw William President & CEO	Award	50,000	—	—	98,012	Form 4
Oct 19, 2022	Hinshaw William President & CEO	Sale	16,000	$1.56	$25K	82,012	Form 4
Oct 13, 2022	AFEYAN NOUBAR Director	Purchase	2,757,333	$1.64	$4.52M⚡	14,101,638	Form 4
Oct 13, 2022	Flagship Ventures Fund IV General Partner LLC 10 percent owner	Purchase	2,757,333	$1.64	$4.52M⚡	14,101,638	Form 4
Oct 13, 2022	AFEYAN NOUBAR Director	Purchase	2,743,902	$1.64	$4.50M⚡	11,344,305	Form 4
Oct 13, 2022	Flagship Ventures Fund IV General Partner LLC 10 percent owner	Purchase	2,743,902	$1.64	$4.50M⚡	11,344,305	Form 4
Oct 13, 2022	Flagship Ventures Fund IV General Partner LLC 10 percent owner	Purchase	919,111	$1.64	$1.51M⚡	6,299,611	Form 4
Oct 13, 2022	AFEYAN NOUBAR Director	Purchase	919,111	$1.64	$1.51M⚡	6,299,611	Form 4
Oct 13, 2022	AFEYAN NOUBAR Director	Purchase	914,634	$1.64	$1.50M⚡	5,380,500	Form 4
Oct 13, 2022	Flagship Ventures Fund IV General Partner LLC 10 percent owner	Purchase	914,634	$1.64	$1.50M⚡	5,380,500	Form 4
Oct 13, 2022	Flagship Ventures Fund IV General Partner LLC 10 percent owner	Purchase	3,048,780	$1.64	$5.00M⚡	3,048,780	Form 4
Oct 13, 2022	AFEYAN NOUBAR Director	Purchase	3,048,780	$1.64	$5.00M⚡	3,048,780	Form 4
Oct 13, 2022	Societe des Produits Nestle S.A. 10 percent owner	Purchase	3,658,536	$1.64	$6.00M⚡	11,105,438	Form 4
Oct 13, 2022	NESTLE SA Director	Purchase	3,658,536	$1.64	$6.00M⚡	11,105,438	Form 4
May 19, 2022	Epstein David R Director	Award	47,059	—	—	209,756	Form 4
Jun 1, 2022	Koziel Margaret Chief Medical Officer	Sale	590	$2.01	$1K	26,109	Form 4
Mar 16, 2022	Hinshaw William President & CEO	Purchase	13,089	$1.91	$25K	48,012	Form 4
Mar 16, 2022	Fehlner Paul SVP & Chief Legal Officer	Purchase	10,471	$1.91	$20K	20,802	Form 4
Mar 16, 2022	Epstein David R Director	Purchase	26,178	$1.91	$50K	161,162	Form 4
Mar 16, 2022	Crane Robert CFO	Purchase	39,267	$1.91	$75K	39,267	Form 4
Mar 16, 2022	Flagship Ventures Fund IV General Partner LLC 10 percent owner	Purchase	3,791,623	$1.91	$7.24M⚡	8,600,403	Form 4
Mar 16, 2022	AFEYAN NOUBAR Director	Purchase	1,579,843	$1.91	$3.02M⚡	4,465,866	Form 4
Mar 16, 2022	Flagship Ventures Fund IV General Partner LLC 10 percent owner	Purchase	1,579,843	$1.91	$3.02M⚡	4,465,866	Form 4

Koziel Margaret

Chief Medical Officer

Sale

Date

Mar 1

679

Price

$0.58

Value

$394

View Form 4 on SEC.gov

Fehlner Paul

SVP & Chief Legal Officer

Sale

Date

Feb 10

5,221

Price

$0.66

Value

$3K

View Form 4 on SEC.gov

Hinshaw William

President & CEO

Award

Date

Oct 17

50,000

Price

—

Value

—

View Form 4 on SEC.gov

Hinshaw William

President & CEO

Sale

Date

Oct 19

16,000

Price

$1.56

Value

$25K

View Form 4 on SEC.gov

AFEYAN NOUBAR

Director

Purchase

Date

Oct 13

2,757,333

Price

$1.64

Value

$4.52M ⚡

View Form 4 on SEC.gov

Flagship Ventures Fund IV General Partner LLC

10 percent owner

Purchase

Date

Oct 13

2,757,333

Price

$1.64

Value

$4.52M ⚡

View Form 4 on SEC.gov

AFEYAN NOUBAR

Director

Purchase

Date

Oct 13

2,743,902

Price

$1.64

Value

$4.50M ⚡

View Form 4 on SEC.gov

Flagship Ventures Fund IV General Partner LLC

10 percent owner

Purchase

Date

Oct 13

2,743,902

Price

$1.64

Value

$4.50M ⚡

View Form 4 on SEC.gov

Flagship Ventures Fund IV General Partner LLC

10 percent owner

Purchase

Date

Oct 13

919,111

Price

$1.64

Value

$1.51M ⚡

View Form 4 on SEC.gov

AFEYAN NOUBAR

Director

Purchase

Date

Oct 13

919,111

Price

$1.64

Value

$1.51M ⚡

View Form 4 on SEC.gov

AFEYAN NOUBAR

Director

Purchase

Date

Oct 13

914,634

Price

$1.64

Value

$1.50M ⚡

View Form 4 on SEC.gov

Flagship Ventures Fund IV General Partner LLC

10 percent owner

Purchase

Date

Oct 13

914,634

Price

$1.64

Value

$1.50M ⚡

View Form 4 on SEC.gov

Flagship Ventures Fund IV General Partner LLC

10 percent owner

Purchase

Date

Oct 13

3,048,780

Price

$1.64

Value

$5.00M ⚡

View Form 4 on SEC.gov

AFEYAN NOUBAR

Director

Purchase

Date

Oct 13

3,048,780

Price

$1.64

Value

$5.00M ⚡

View Form 4 on SEC.gov

Societe des Produits Nestle S.A.

10 percent owner

Purchase

Date

Oct 13

3,658,536

Price

$1.64

Value

$6.00M ⚡

View Form 4 on SEC.gov

NESTLE SA

Director

Purchase

Date

Oct 13

3,658,536

Price

$1.64

Value

$6.00M ⚡

View Form 4 on SEC.gov

Epstein David R

Director

Award

Date

May 19

47,059

Price

—

Value

—

View Form 4 on SEC.gov

Koziel Margaret

Chief Medical Officer

Sale

Date

Jun 1

590

Price

$2.01

Value

$1K

View Form 4 on SEC.gov

Hinshaw William

President & CEO

Purchase

Date

Mar 16

13,089

Price

$1.91

Value

$25K

View Form 4 on SEC.gov

Fehlner Paul

SVP & Chief Legal Officer

Purchase

Date

Mar 16

10,471

Price

$1.91

Value

$20K

View Form 4 on SEC.gov

Epstein David R

Director

Purchase

Date

Mar 16

26,178

Price

$1.91

Value

$50K

View Form 4 on SEC.gov

Crane Robert

CFO

Purchase

Date

Mar 16

39,267

Price

$1.91

Value

$75K

View Form 4 on SEC.gov

Flagship Ventures Fund IV General Partner LLC

10 percent owner

Purchase

Date

Mar 16

3,791,623

Price

$1.91

Value

$7.24M ⚡

View Form 4 on SEC.gov

AFEYAN NOUBAR

Director

Purchase

Date

Mar 16

1,579,843

Price

$1.91

Value

$3.02M ⚡

View Form 4 on SEC.gov

Flagship Ventures Fund IV General Partner LLC

10 percent owner

Purchase

Date

Mar 16

1,579,843

Price

$1.91

Value

$3.02M ⚡

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 2

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About AXLA insider trading

AXLA insider trades

Axcella Health Inc. (AXLA) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including AXLA. Over the past 12 months, 0 insiders have filed transactions with the SEC. AXLA insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Axcella Health Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

AXLA insider trading · 5 questions

The insiders of Axcella Health Inc. (AXLA) include executives and directors such as AXLA, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

AXLA board member insider tradingwho are AXLA insidersAXLA insider rosterAxcella Health Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026